Tumor CD8+ T cell dysfunction-driving factors, regulation, markers, repair Tumor CD8+ T cell dysfunction-driving factors, regulation, markers, repair. The...
News
Latest news about Medical technology, drugs, equipment, diseases and related treatment.
The Cause Dolution strategy and determination of CAR-T tonic signal Cause Dolution strategy and determination of CAR-T tonic signal. ...
Bispecific antibodies for the treatment of triple-negative breast cancer Bispecific antibodies for the treatment of triple-negative breast cancer....
Nature: The reason Why elderly people are prone to cancer is related to mitochondria The reason elderly people are...
Moderna's many mRNA vaccines will gradually enter clinical trials Moderna's many mRNA vaccines will gradually enter clinical trials. Moderna...
Diffuse large B-cell lymphoma (DLBCL): Lenzilumab plus CAR-T cell therapy 100% effective DLBCL: Lenzilumab combined with CAR-T cell therapy...
ADDADM: The ecological imbalance of gum bacteria may be directly related to Alzheimer's disease biomarkers Gum bacteria may be...
"Black Technology": Proton therapy for retinoblastoma "Black Technology": Proton therapy for retinoblastoma. Retinoblastoma is the most common ocular malignant...
Swollen lymph nodes may be Hodgkin's lymphoma Swollen lymph nodes may be Hodgkin's lymphoma. The lymph nodes in the...
JAHA: Late-stage survival rate of PCI treatment for CTO Patients: 10-year follow-up study JAHA: Late-stage survival rate of PCI...
Cell: Bone microenvironment promotes cancer metastasis Cell: Bone microenvironment promotes cancer metastasis. The skeletal microenvironment surrounding ER+...
United States Government lifts research restrictions on human fetal tissues United States Government lifts research restrictions on human fetal...
New TILs immunotherapy made the patient cancer-free for five years New TILs immunotherapy made the patient cancer-free for five...
CAR-T therapy treat patients with recurrent peripheral T-cell lymphoma to get out of the treatment dilemma! CAR-T therapy treat...
Lung cancer: Cimeprizumab (Drug C) has a powerful single-agent treatment effect Lung cancer: Cimeprizumab (Drug C) has a powerful...
LGGs: Proton therapy for low-grade glioma LGGs: Proton therapy for low-grade glioma. Is proton therapy for low-grade gliomas effective?...
Linker strategy in bispecific antibody technology platform Linker strategy in bispecific antibody technology platform. The most important point of...
Can the patient have another surgery if bowel cancer has recurred? Can the patient have another surgery if bowel cancer...
How to deal with breast cancer recurrence and metastasis? How to deal with breast cancer recurrence and metastasis? What factors...
First drug for Childhood achondroplasia is expected to come soon First drug for Childhood achondroplasia is expected to come...
AACR: A new way to enhance immunotherapy AACR: A new way to enhance immunotherapy. Immunotherapy is a broad category...
The biological clock is synchronized with the body and also with the virus... The biological clock is synchronized with...
Develop a safe and effective COVID-19 vaccine based on past experience Develop a safe and effective COVID-19 vaccine based on...
Gastric cancer: Amgen’s FGFR2b targeted monoclonal antibody bemarituzumab Innovative therapy for gastric cancer: Amgen’s FGFR2b targeted monoclonal antibody bemarituzumab...
Progress in personalized nano-tumor vaccines Progress in personalized nano-tumor vaccines. Individualized tumor vaccines are very important in tumor immunotherapy....
Stroke: The number of bolt removals will be discussed again Stroke: The number of bolt removals will be discussed...
Still need to be vigilant even 95% of lung nodules are benign lesions Still need to be vigilant even...
France will continue to use both AstraZeneca and Johnson & Johnson COVID-19 vaccines France will continue to use both...
Cancer patients is hopeless if PD-1 resistance occured? Cancer patients is hopeless if PD-1 resistance occured? Many PD-1 monoclonal...
Evaluation index for clinical efficacy of solid tumors (RECIST1.1) Evaluation index for clinical efficacy of solid tumors (RECIST1.1). The therapeutic...